Trial NCT00879970

View at ClinicalTrials.gov 
Org. Study IDs: 111960

Last trial update was posted on 2017-04-18

MeSH Interventions

Pioglitazone Rosiglitazone Vitamin D

MeSH Conditions

Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

FDA has placed the trial on full clinical hold.

Limitations And Caveats

The intended duration of this study was approximately 5.5 years. However, the trial was stopped prematurely because of regulatory concerns after a mean of 162 days without consideration of the accrued data.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID